Abstract
Of 28 children with sarcoidosis, who have a mean follow-up period of approximately nine years, five (18 percent) have sustained severe damage from the disease. Two of these patients suffer from blindness, and three others have severe restrictive pulmonary disease. There has so far been no fatality. The presence of cutaneous lesions suggests a guarded prognosis, but the effectiveness of corticosteroid therapy cannot be accurately determined. The degree of pulmonary involvement evident on the chest x-ray film at the time of diagnosis is not always indicative of the ultimate prognosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
